| Literature DB >> 20828371 |
Jasper Truijen1, Shyrin C A T Davis, Wim J Stok, Yu-Sok Kim, David J van Westerloo, Marcel Levi, Tom van der Poll, Berend E Westerhof, John M Karemaker, Johannes J van Lieshout.
Abstract
Acute psychological stress challenges the cardiovascular system with an increase in BP (blood pressure), HR (heart rate) and reduced BRS (baroreflex sensitivity). β-adrenergic blockade enhances BRS during rest, but its effect on BRS during acute psychological stress is unknown. This study tested the hypothesis that BRS is higher during acute psychological stress in healthy subjects under β-adrenergic blockade. Twenty healthy novice male bungee jumpers were randomized and studied with (PROP, n=10) or without (CTRL, n=10) propranolol. BP and HR responses and BRS [cross-correlation time-domain (BRSTD) and cross-spectral frequency-domain (BRSFD) analysis] were evaluated from 30 min prior up to 2 h after the jump. HR, cardiac output and pulse pressure were lower in the PROP group throughout the study. Prior to the bungee jump, BRS was higher in the PROP group compared with the CTRL group [BRSTD: 28 (24-42) compared with 17 (16-28) ms·mmHg-1, P<0.05; BRSFD: 27 (20-34) compared with 14 (9-19) ms·mmHg-1, P<0.05; values are medians (interquartile range)]. BP declined after the jump in both groups, and post-jump BRS did not differ between the groups. In conclusion, during acute psychological stress, BRS is higher in healthy subjects treated with non-selective β-adrenergic blockade with significantly lower HR but comparable BP.Entities:
Mesh:
Substances:
Year: 2011 PMID: 20828371 PMCID: PMC2973234 DOI: 10.1042/CS20100137
Source DB: PubMed Journal: Clin Sci (Lond) ISSN: 0143-5221 Impact factor: 6.124
Figure 1Protocol
Timing of the measurements at stress (t−30 min), and maximum stress (t−1 min) prior to the bungee jump and 10 min (t+10 min) and 120 min (t+120 min) post-stress following the bungee jump. BPf, continuous finger BP; HRf, HR from continuous finger BP.
BRS, BP and HRV
Values are medians (IQR). *P<0.05 and **P<0.01 compared with CTRL; ††P<0.01 compared with t−30 min.
| Parameter | Group | ||
|---|---|---|---|
| BRSTD (ms·mmHg−1) | CTRL | 17 (16–28) | 24 (14–27) |
| PROP | 28 (24–42)* | 27 (17–32) | |
| BRSFD (ms·mmHg−1) | CTRL | 14 (9–19) | 19 (9–22) |
| PROP | 27 (20–34)* | 18 (16–19) | |
| BPVLF (mmHg2·Hz−1) | CTRL | 8 (4–15) | 5 (3–10) |
| PROP | 4 (1–7) | 3 (2–7) | |
| HRVLF (ms2·Hz−1) | CTRL | 1890 (698–2730) | 754 (472–1720) |
| PROP | 3780 (1290–6360) | 1310 (702–1450) | |
| HRVHF (ms2·Hz−1) | CTRL | 170 (66–186) | 653 (234–1300)†† |
| PROP | 884 (506–2060)** | 1690 (340–2310) |
Figure 2BRS with compared with or without β-blockade
BRS with (PROP; black bars) compared with without (CTRL; grey bars) propranolol pre-jump (t−30 min; left-hand panel) and post-jump (t+120 min; right-hand panel). Values are medians (IQR).
Cardiovascular variables
Values are presented as means±S.D. *P<0.05, **P<0.01 and ***P<0.001 compared with the CTRL group; †P<0.05, ††P<0.01 and †††P<0.001 compared with t−30 min; ‡P<0.05 and ‡‡P<0.01 compared with supine. DBP, diastolic BP; o, oscillometric brachial pressure.
| Supine | Upright | ||||||
|---|---|---|---|---|---|---|---|
| Parameter | Group | ||||||
| HRo (beats·min−1) | CTRL | 74±14 | 67±11 | 88±17‡‡ | 114±26††† | 92±17 | 93±17‡‡ |
| PROP | 52±8*** | 53±7** | 58±9***‡‡ | 65±10***†† | 59±10*** | 69±10***††‡‡ | |
| SBPo (mmHg) | CTRL | 146±11 | 129±9††† | 144±14 | 160±21†† | 151±10 | 128±13††† |
| PROP | 134±15 | 123±12†† | 136±16 | 155±23†† | 139±20 | 120±11†† | |
| DBPo (mmHg) | CTRL | 81±10 | 72±8††† | 92±8‡‡ | 100±11† | 88±9 | 82±7†††‡‡ |
| PROP | 80±12 | 65±5†† | 92±11‡‡ | 103±12† | 88±16 | 80±6††‡‡ | |
| MAPo (mmHg) | CTRL | 103±10 | 91±8††† | 110±9‡‡ | 120±12†† | 109±8 | 97±8†††‡ |
| PROP | 98±13 | 85±6†† | 107±11‡‡ | 120±14†† | 105±17 | 93±8††‡‡ | |
| PPo (mmHg) | CTRL | 65±8 | 58±4† | 52±9‡‡ | 60±19 | 63±10† | 45±9††‡‡ |
| PROP | 54±9** | 57±10 | 44±11‡ | 52±17 | 50±9** | 40±6‡‡ | |
| CO (l·min−1) | CTRL | 5.9±0.8 | 5.0±1.1 | 4.7±0.6‡ | − | − | 4.5±1.1 |
| PROP | 4.2±1.1*** | 3.8±0.4** | 3.3±0.9**‡‡ | − | − | 3.2±0.5**‡‡ | |
| SV (ml) | CTRL | 78±10 | 74±15 | 54±16‡‡ | − | − | 47±12‡‡ |
| PROP | 81±22 | 70±7 | 55±14‡‡ | − | − | 45±4‡‡ | |
| SVR (mmHg·s·ml−1) | CTRL | 0.85±0.18 | 0.92±0.21 | 1.24±0.28‡‡ | − | − | 1.24±0.42‡‡ |
| PROP | 1.05±0.32 | 1.03±0.12 | 1.69±0.44*‡ | − | − | 1.47±0.16‡‡ | |
Figure 3BP and HR response to bungee jumping
BP and HR in subjects treated with propranolol (PROP; ●) and in control subjects (CTRL; ○). The instant of the bungee jump is indicated by the dotted line. Values are mean±S.D. *P<0.001 compared with the CTRL group; †P<0.05 compared with t−30 min. bpm, beats·min−1.
Figure 4BP and HR response to active standing
BP and HR response to active standing with stress and post-stress before (t−30 min) and after (t+120 min) the jump with (PROP) and without propranolol (CTRL). Active standing was performed at 0 s. Values are means±S.E.M.